US Stock MarketDetailed Quotes

Cardiff Oncology (CRDF)

Watchlist
  • 1.720
  • +0.050+2.99%
Close Apr 24 15:59 ET
  • 1.719
  • -0.001-0.08%
Post 20:01 ET
117.60MMarket Cap-2.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cardiff Oncology (CRDF) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-13.18%593K
60.93%243K
-27.27%120K
-25.77%121K
-46.83%109K
39.96%683K
-3.21%151K
17.02%165K
50.93%163K
146.99%205K
Operating revenue
-13.18%593K
60.93%243K
-27.27%120K
-25.77%121K
-46.83%109K
39.96%683K
-3.21%151K
17.02%165K
50.93%163K
146.99%205K
Cost of revenue
Gross profit
Operating expense
0.44%49.55M
-36.57%8.07M
-5.26%12.09M
17.23%14.9M
30.10%14.49M
7.48%49.33M
21.31%12.72M
16.47%12.77M
3.18%12.71M
-8.22%11.14M
Selling and administrative expenses
13.96%14.22M
-0.53%3M
24.66%3.9M
3.20%3.32M
28.24%4.01M
-4.30%12.48M
10.50%3.01M
6.36%3.13M
-25.16%3.22M
1.52%3.13M
-Selling and marketing expense
----
----
----
----
----
----
----
-25.37%400K
-21.40%459K
----
-General and administrative expense
13.96%14.22M
-0.53%3M
24.66%3.9M
3.20%3.32M
28.24%4.01M
-4.30%12.48M
10.50%3.01M
6.36%3.13M
-25.16%3.22M
1.52%3.13M
Research and development costs
-4.13%35.33M
-47.75%5.08M
-14.97%8.2M
21.98%11.58M
30.83%10.48M
12.16%36.85M
25.11%9.71M
20.17%9.64M
18.37%9.49M
-11.53%8.01M
Operating profit
-0.64%-48.96M
37.74%-7.83M
4.98%-11.97M
-17.79%-14.78M
-31.55%-14.38M
-7.13%-48.65M
-21.68%-12.57M
-16.46%-12.6M
-2.76%-12.55M
9.28%-10.93M
Net non-operating interest income expense
-4.76%3.1M
-22.24%612K
-3.37%716K
3.73%835K
1.62%941K
-19.91%3.26M
-21.92%787K
-30.62%741K
-23.55%805K
-1.49%926K
Non-operating interest income
-4.76%3.1M
-22.24%612K
-3.37%716K
3.73%835K
1.62%941K
-19.91%3.26M
-21.92%787K
-30.62%741K
-23.55%805K
-1.49%926K
Other net income (expense)
112.82%5K
50.00%-1K
97.37%-1K
275.00%7K
60.20%-39K
84.62%-2K
-76.19%5K
-860.00%-38K
96.40%-4K
Other non- operating income (expenses)
112.82%5K
50.00%-1K
----
97.37%-1K
275.00%7K
60.20%-39K
84.62%-2K
-76.19%5K
-860.00%-38K
96.40%-4K
Income before tax
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
10.80%-10.01M
Income tax
Net income
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
10.80%-10.01M
Net income continuous Operations
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
10.80%-10.01M
Minority interest income
Net income attributable to the parent company
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
10.80%-10.01M
Preferred stock dividends
4.17%25K
16.67%7K
0.00%6K
0.00%6K
0.00%6K
0.00%24K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
Other preferred stock dividends
Net income attributable to common stockholders
-0.93%-45.88M
38.75%-7.22M
5.03%-11.26M
-18.37%-13.95M
-34.17%-13.44M
-9.62%-45.46M
-26.22%-11.79M
-21.81%-11.86M
-5.63%-11.78M
10.79%-10.02M
Basic earnings per share
27.37%-0.69
47.62%-0.11
32.00%-0.17
19.23%-0.21
9.09%-0.2
-2.15%-0.95
0.00%-0.21
-13.64%-0.25
-4.00%-0.26
12.00%-0.22
Diluted earnings per share
27.37%-0.69
47.62%-0.11
32.00%-0.17
19.23%-0.21
9.09%-0.2
-2.15%-0.95
0.00%-0.21
-13.64%-0.25
-4.00%-0.26
12.00%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -13.18%593K60.93%243K-27.27%120K-25.77%121K-46.83%109K39.96%683K-3.21%151K17.02%165K50.93%163K146.99%205K
Operating revenue -13.18%593K60.93%243K-27.27%120K-25.77%121K-46.83%109K39.96%683K-3.21%151K17.02%165K50.93%163K146.99%205K
Cost of revenue
Gross profit
Operating expense 0.44%49.55M-36.57%8.07M-5.26%12.09M17.23%14.9M30.10%14.49M7.48%49.33M21.31%12.72M16.47%12.77M3.18%12.71M-8.22%11.14M
Selling and administrative expenses 13.96%14.22M-0.53%3M24.66%3.9M3.20%3.32M28.24%4.01M-4.30%12.48M10.50%3.01M6.36%3.13M-25.16%3.22M1.52%3.13M
-Selling and marketing expense -----------------------------25.37%400K-21.40%459K----
-General and administrative expense 13.96%14.22M-0.53%3M24.66%3.9M3.20%3.32M28.24%4.01M-4.30%12.48M10.50%3.01M6.36%3.13M-25.16%3.22M1.52%3.13M
Research and development costs -4.13%35.33M-47.75%5.08M-14.97%8.2M21.98%11.58M30.83%10.48M12.16%36.85M25.11%9.71M20.17%9.64M18.37%9.49M-11.53%8.01M
Operating profit -0.64%-48.96M37.74%-7.83M4.98%-11.97M-17.79%-14.78M-31.55%-14.38M-7.13%-48.65M-21.68%-12.57M-16.46%-12.6M-2.76%-12.55M9.28%-10.93M
Net non-operating interest income expense -4.76%3.1M-22.24%612K-3.37%716K3.73%835K1.62%941K-19.91%3.26M-21.92%787K-30.62%741K-23.55%805K-1.49%926K
Non-operating interest income -4.76%3.1M-22.24%612K-3.37%716K3.73%835K1.62%941K-19.91%3.26M-21.92%787K-30.62%741K-23.55%805K-1.49%926K
Other net income (expense) 112.82%5K50.00%-1K97.37%-1K275.00%7K60.20%-39K84.62%-2K-76.19%5K-860.00%-38K96.40%-4K
Other non- operating income (expenses) 112.82%5K50.00%-1K----97.37%-1K275.00%7K60.20%-39K84.62%-2K-76.19%5K-860.00%-38K96.40%-4K
Income before tax -0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M10.80%-10.01M
Income tax
Net income -0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M10.80%-10.01M
Net income continuous Operations -0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M10.80%-10.01M
Minority interest income
Net income attributable to the parent company -0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M10.80%-10.01M
Preferred stock dividends 4.17%25K16.67%7K0.00%6K0.00%6K0.00%6K0.00%24K0.00%6K0.00%6K0.00%6K0.00%6K
Other preferred stock dividends
Net income attributable to common stockholders -0.93%-45.88M38.75%-7.22M5.03%-11.26M-18.37%-13.95M-34.17%-13.44M-9.62%-45.46M-26.22%-11.79M-21.81%-11.86M-5.63%-11.78M10.79%-10.02M
Basic earnings per share 27.37%-0.6947.62%-0.1132.00%-0.1719.23%-0.219.09%-0.2-2.15%-0.950.00%-0.21-13.64%-0.25-4.00%-0.2612.00%-0.22
Diluted earnings per share 27.37%-0.6947.62%-0.1132.00%-0.1719.23%-0.219.09%-0.2-2.15%-0.950.00%-0.21-13.64%-0.25-4.00%-0.2612.00%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -